Novel Therapeutics for Lupus Nephritis Management
Emerging Therapeutic Targets:
Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients
Stay informed about the latest therapeutic options for managing hyperkalemia in non-dialysis CKD.
Explore the latest therapies, including ARNI and finerenone, proven to slow CKD progression and protect...
Learn the latest KDIGO recommendations for evaluating CKD risk in adults and managing stages G3-G5
Learn how anemia in CKD significantly raises healthcare expenses—uncover the full economic impact.
Discover the latest diagnostic and management recommendations for lupus nephritis from KDIGO 2024.
Please login/register with us to continue using DocVidya